Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with cetuximab. Median progression-free survival was 5.6 ...
1. Greater early-life body size is not an independent risk factor for colorectal cancer (aside from distal colon cancer) but ...
1. The use of proguanil/atovaquone amongst individuals with a family history of colorectal cancer (CRC) was associated with a decreased ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://s25qthea.wpenginepowered.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
1. The median overall survival for pembrolizumab versus chemotherapy was not statistically significant difference. 2. Common grade 3 or higher ...
1. Atezolizumab plus capecitabine + bevacizumab performed marginally better with regards to progression free survival in patients with metastatic colorectal ...
1. In this study, long-term high sulfur microbial diet was associated with increased risk of colorectal cancer. 2. Body weight ...
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
1. A randomized controlled trial of patients with stage II and III rectal cancer found that adding oxaliplatin to the ...
1. Incomplete resection of colon segments was shown to significantly increase the risk of future neoplasia compared to segments with ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.